• Novel Imaging Application of Chemigenius

Microscopy & Microtechniques

Novel Imaging Application of Chemigenius

Dec 20 2005

Syngene, a leading manufacturer of image analysis solutions, is pleased to announce its ChemiGenius2 multi-purpose imaging system, is being used by the University of Oklahoma for a fluorescence imaging application which is part of an important study into the causes of blindness associated with diabetes.

Scientists at the University of Oklahoma College of Medicine are using the ChemiGenius2 in a unique way to analyse slides of fluorescently labelled eye tissue. The system is also in use for routine tasks such as checking the quality and size of DNA fragments and determining protein expression by Western blotting. The ultimate goal of this research is to develop natural peptides as new non-invasive therapies to block vascular leakage in the eyes, preventing retinal degeneration and subsequent blindness caused by diseases such as diabetes.

Digital Edition

Labmate UK & Ireland September 2021

September 2021

In This Edition Articles - The challenges of Biosample access and what needs to change - Innovative UK exports must gather income - not dust Spotlight Life Sciences - How a Pipettin...

View all digital editions

Events

Water Expo Nigeria 2021 - NEW DATES

Sep 21 2021 Lagos, Nigeria

17th Confocal Raman Imaging Symposium

Sep 27 2021 Virtual event

BCEIA 2021

Sep 27 2021 Beijing, China

Photonex & Vacuum Expo

Sep 28 2021 Glasgow, Scotland

Chemspec Digital 2021

Sep 29 2021 Online event

View all events